• 검색 결과가 없습니다.

– 2010 Korean National Health and Nutrition Examination Survey Data Associations of Low Bone Mass with High Serum Ferritin in the Korean General Female Population: Analysis of 2008

N/A
N/A
Protected

Academic year: 2021

Share "– 2010 Korean National Health and Nutrition Examination Survey Data Associations of Low Bone Mass with High Serum Ferritin in the Korean General Female Population: Analysis of 2008"

Copied!
9
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

Received: July 30, 2015 Revised: August 23, 2015 Accepted: September 16, 2015

Corresponding Author: Yangho Kim, Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 682-714, Korea

Tel: +82-10-2294-5973, Fax: +82-52-250-7289, E-mail: [email protected]

Associations of Low Bone Mass with High Serum Ferritin in the Korean General Female Population: Analysis of 2008–2010 Korean National Health and

Nutrition Examination Survey Data

Byung-Kook Lee

1

, Yangho Kim

2

1

Department of Preventive Medicine, College of Medicine, Soonchunhyang University, Asan,

2

Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Objectives: The present study was performed to evaluate the association between serum ferritin concentrations and bone mineral density (BMD) in a representative Korean general population.

Methods: This was a cross-sectional study based on data obtained in the Korean National Health and Nutrition Examination Survey (2008~2010). The present cross-sectional analysis was restricted to participants

≥20 years of age who completed the health examination survey and BMD measurement (n=15,538).

Results: In multiple linear regression analysis of log

2

-transformed serum ferritin as a continuous variable on BMD, the differences in BMD levels associated with doubling of serum ferritin were -0.0022~-0.0057 in a large representative sample of South Korean women, but not in men. In this large representative sample of South Korean women, elevated serum ferritin level was consistently associated with the prevalence of low bone mass for chronological age. However, there were no significant associations of ferritin level and low bone mass in men.

Conclusion: An association of elevated ferritin level with lower BMD level was observed in the general female population. Thus, our results have substantial public health implications.

Key Words: Bone mineral density, Ferritin, Iron, Bone mass

Osteoporosis has become a global issue and a health threat according to the World Health Organization.

1

Over the past several years, there has been considerable progression in studies of iron overload and osteo- porosis.

2

Iron is an essential nutrient with crucial biolo- gical functions, including basic roles in hemoglobin and the immune response. Iron is also a catalyst for the formation of hydroxyl radicals, which are powerful prooxidants that attack cellular membrane lipids, proteins, and nucleic acids, resulting in tissue damage.

3,4

Hence, increasing iron stores to levels beyond the tolerable

threshold of cells can contribute to various types of

pathology. The liver, pancreas, heart, and other endo-

crine organs are frequently damaged in iron-overload

states, such as hemochromatosis and recurrent trans-

fusions in diseases such as thalassemia.

5,6

In vitro

studies have shown that iron inhibits the differentiation,

proliferation, and activity of osteoblasts,

7,8

whereas it

promotes osteoclast activity by enhancing mitochondrial

biogenesis.

9

In a murine model, iron overload resulted

in increased oxidative stress and bone resorption, leading

to changes in bone microarchitecture and material

(2)

properties, finally resulting in bone loss.

10

Osteoporosis occurs in a variety of clinical conditions associated with iron overload, including hemochromatosis,

11

African hemosiderosis,

12

thalassemia,

13

sickle cell disease,

14

and liver diseases,

15

suggesting that iron overload is a common mechanism responsible for bone loss. How- ever, there have been few epidemiological studies relating iron stores to bone loss, especially in a general population.

16

We performed a cross-sectional study to evaluate the association between serum ferritin concen- trations and bone mineral density (BMD) in a repre- sentative Korean general population.

MATERIALS AND METHODS

1. Design and data collection

This study used data obtained in the Korea National Health and Nutrition Examination Survey (KNHANES) for 2008~2010, representing the second and third years of KNHANES IV (2007~2009) and the first year of KNHANES V (2010~2012). KNHANES is conducted annually, using a rolling sampling design that involves a complex, stratified, multistage, probability-cluster survey of a representative sample of the non-institu- tionalized civilian population in South Korea. Detailed information regarding the design of the survey was provided previously.

17

Briefly, the survey consisted of three components: a health interview survey, a health examination survey, and a nutrition survey. The present cross-sectional analysis was restricted to participants ≥ 20 years of age who completed the health examination survey and BMD measurement (n=15538). Information on age, education, smoking history, and alcohol intake was collected during the health interview. Height and weight measurements were performed with the parti- cipants wearing light clothing and no shoes. Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters. Obesity was categorized into three groups: lean (BMI<18.5), normal (18.5≤BMI<25), and obese (BMI≥25). Age,

as reported at the time of the health interview, was categorized into six groups (20~29, 30~39, 40~49, 50~59, 60~69, and ≥70 years). Education level was categorized into three groups: below high school, high school, and college or higher. Smoking status was divided into three categories based on self-reported cigarette use: current smoker, past smoker, and never-smoker. Never-smokers had smoked <100 cigarettes in their lifetime, and participants who smoked

≥100 cigarettes were classified as past or current smokers based on current use. Alcohol consumption was assessed by asking the participants about their drinking behavior during the month prior to the interview. The participants were asked about their average frequency (days per month) of alcoholic beverage consumption and amount (in mL) of alcoholic beverages ingested on a single occasion. The responses were converted into the amount of pure alcohol (in g) consumed per day. Alcohol consumption status was categorized into four groups according to average daily alcohol consumption: nondrinker, light drinker (1~15 g), moderate drinker (16~30 g), and heavy drinker (>30 g). Regular walking was defined as indoor or outdoor walking for ≥30 min at a time at least three times per week. Regular exercise was defined as participating in moderate exercise (slow swimming, doubles tennis, volleyball, or occupational or recreational activity invol- ving carrying light objects) on a regular basis for ≥30 min at a time at least three times per week, or partici- pating in vigorous exercise (running, climbing, fast cycling, fast swimming, football, basketball, rope jum- ping, squash, singles tennis, or occupational or recrea- tional activity involving carrying heavy objects) ≥20 min at a time at least once per week.

2. Measurement of BMD

BMD was measured in the lumbar spine, five regions

of the femur (femoral neck, trochanter, intertrochanter,

Ward’s triangle, and the total femur), and in the whole

body by dual-energy X-ray absorptiometry using a

(3)

DISCOVERY-W fan-beam densitometer (Hologic, Bedford, MA) at the mobile health examination site.

Pregnant women and subjects who had undergone contrast-agent-based examination within a week of the survey were excluded. Subjects were also excluded if their reported weight exceeded the weight and height limits of the DXA scan table (136 kg and 196 cm, respectively). BMD was classified into two categories;

normal (Z-score >=-1.0) and low bone mass (Z-score

<-1.0) based on Z-score of BMD calculated chrono- logically according to 6 age groups in any of total femur, femur neck, or lumbar spine.

3. Measurement of serum ferritin

Serum ferritin was measured by an immune radio- metric assay method using a 1470 WIZARD gamma- counter (PerkinElmer, Turku, Finland), and blood hemoglobin was measured with an XE-2100D (Sysmex, Tokyo, Japan).

To assess the association with BMD, serum ferritin was categorized into quartile (Q) levels: 1st Q (serum ferritin <18.09μg/L for women, <64.31μg/L for Men), 2nd Q (serum ferritin 18.09~35.96μg/L for women and 64.31~98.05 for men), 3rd Q (serum ferritin 35.97~

60.93μg/L for women and 98.06~149.21 for men), and 4th Q (serum ferritin>60.93μg/L for women and >

149.21 for men).

4. Statistical analysis

Statistical analyses were performed using SAS software (ver. 9.3; SAS Institute, Cary, NC) and SUDAAN (Release 10.0; Research Triangle Institute, Research Triangle Park, NC), a software package that incor- porates sample weights and adjusts analyses for the complex sample design of the survey. Survey sample weights were used in all analyses to produce estimates that were representative of the non-institutionalized civilian Korean population.

To compare the means of the levels of serum ferritin and BMDs of the total femur, femur neck, and lumbar

spine in different demographic and lifestyle groups while controlling for covariates (age, gender, smoking status, drinking status, and residence area), adjusted means and (standard error; SE) were calculated by analysis of covariance (ANCOVA) calculated by the Proc Regress function.

Multivariate linear regression analyses were then performed to determine the differences (95% CI) in BMDs of total femur, femur neck, and lumbar spine by serum ferritin level after covariate adjustment. Log

2

- transformed serum ferritin level as a continuous inde- pendent variable due to its skewed distribution was regressed on three BMD levels, whereas Q of serum ferritin for women and men was used as a categorical independent variable for regression on three BMD levels. Covariates used in the analysis were age, resi- dence area, BMI, smoking & drinking status, education level, regular exercise and walking for men, with addition of menopausal status, hormone treatment, and use of oral contraceptives for women.

Next, using logistic regression analysis, odds ratios (ORs) and 95% CIs for low bone mass for chronolo- gical age by serum ferritin level were then determined according to log

2

-transformed serum ferritin (as a conti- nuous variable) and Q of serum ferritin (as a catego- rical variable) after adjusting for the same covariates as in regression analyses.

RESULTS

Adjusted means (SE) of serum ferritin and BMDs of total femur, femur neck, and lumbar spine are shown in Table 1.

The adjusted mean (SE) of serum ferritin, BMDs of

total femur, femur neck, and lumbar spine for women

were 52.63 (0.88)μg/L, 0.864 (0.002) g/cm

2

, 0.723

(0.002) g/cm

2

, and 0.927 (0.002) g/cm

2

, respectively,

and those for men were 114.9 (1.46)μg/L, 0.986

(0.002) g/cm

2

, 0.816 (0.002) g/cm

2

, 0.965 (0.002)

g/cm

2

, respectively.

(4)

Table 1. Means and standard error of serum ferritin and bone mineral densities of adult population by gender and classification variables after covariate adjustment

Women (n=8898) Men (n=6640)

Classification No Serum ferritin Bone mineral density

No Serum ferritin Bone mineral density

Total Femur Femur Neck Lumbar Spine Total Femur Femur Neck Lumbar Spine All 15538 52.63±0.88 0.864± 0.002 0.723±0.002 0.927±0.002 926 114.9±1.46 0.986±0.002 0.816±0.002 0.965±0.002 Age groups

20~29

30~39 40~49 50~59 60~69

≥70

1205 1856 1770 1623 1413 1031

34.04±1.15 31.83±0.82 35.63±0.87 60.81±1.55**

70.41±1.72**

76.32±2.62**

0.897± 0.003 0.899± 0.003 0.900± 0.003 0.840± 0.003**

0.758± 0.003**

0.680± 0.004**

0.777±0.003 0.761±0.002**

0.749±0.003**

0.686±0.003**

0.609±0.003**

0.539±0.003**

0.963±0.004 0.992±0.003*

0.975±0.003**

0.871±0.004**

0.786±0.004**

0.745±0.005**

1345 1292 1174 1137 766

112.5±2.79 119.4±2.51*

118.6±2.82 134.7±5.28**

119.5±4.08 137.9±4.99**

1.019±0.004 0.987±0.003**

0.983±0.003**

0.964±0.003**

0.935±0.005**

0.874±0.005**

0.909±0.004 0.847±0.003**

0.816±0.003**

0.789±0.003**

0.753±0.004**

0.692±0.005**

0.994±0.004 0.986±0.003 0.971±0.004**

0.954±0.004**

0.959±0.005**

0.934±0.008**

Residence area Urban

Rural

6737 2161

45.90±0.63 47.63±1.43

0.852± 0.001 0.860± 0.003*

0.710±0.001 0.720±0.002**

0.919±0.002 0.919±0.004

4985 1655

120.4±1.74 125.4±3.21

0.975±0.002 0.986±0.004*

0.823±0.002 0.837±0.004**

0.971±0.002 0.981±0.005 Smoking status

Non-smoker

Past smoker Current smoker

8065 336 497

45.65±0.58 50.04±2.60 52.24±2.42**

0.855± 0.001 0.834± 0.006**

0.847± 0.005

0.713±0.001 0.700±0.006*

0.705±0.005

0.920±0.002 0.911±0.006 0.912±0.005

2202 1652 2786

114.7±2.20 126.6±4.32**

124.0±2.11**

0.976±0.003 0.981±0.003 0.977±0.002

0.825±0.003 0.825±0.003 0.827±0.002

0.973±0.003 0.976±0.003 0.972±0.002 Drinking status

Non-drinker

Mild drinker Moderate drinker Heavy drinker

3329 3018 1379 1172

44.38±0.90 45.79±0.94 46.05±1.08 51.17±1.34**

0.847± 0.002 0.852± 0.002**

0.861± 0.003**

0.864± 0.003**

0.702±0.002 0.711±0.002**

0.718±0.003**

0.728±0.003**

0.910±0.003 0.919±0.003*

0.924±0.003**

0.930±0.004**

1104 960 1139 3437

95.87±2.93 108.6±3.24**

116.5±3.07**

131.2±2.35**

0.973±0.004 0.965±0.004 0.976±0.004 0.982±0.002

0.819±0.004 0.817±0.004 0.825±0.004 0.829±0.002

0.972±0.004 0.958±0.005 0.974±0.004 0.977±0.002 Education level

Less than high school

High school College and more

4673 2039 2186

45.58±0.84 46.97±1.13 46.75±0.94

0.846± 0.002 0.865± 0.003**

0.858± 0.003*

0.707±0.002 0.719±0.002**

0.716±0.002*

0.905±0.003 0.929±0.003**

0.934±0.003**

2662 1490 2488

125.3±3.27 117.8±2.78 120.1±2.06

0.966±0.003 0.978±0.003**

0.986±0.002**

0.815±0.003 0.824±0.003 0.835±0.002**

0.961±0.003 0.971±0.003 0.984±0.003**

Obesity Lean

Normal Obese

483 5901 2514

45.47±2.53 45.22±0.70 48.99±1.00

0.771± 0.005 0.841± 0.001**

0.906± 0.002**

0.648±0.005 0.702±0.001**

0.752±0.002**

0.839±0.005 0.906±0.002**

0.971±0.003**

220 4127 2293

106.4±6.58 116.7±2.04 130.8±2.30**

0.851±0.010 0.958±0.002**

1.022±0.003**

0.722±0.009 0.809±0.002**

0.863±0.003**

0.855±0.009 0.960±0.002**

1.006±0.003**

Regular exercise Yes

No

2049 6849

46.27±1.07 46.23±0.61

0.859± 0.002 0.853± 0.001*

0.717±0.002 0.711±0.001*

0.921±0.003 0.918±0.002

1823 4817

117.5±2.99 122.9±1.68

0.989±0.003 0.973±0.002**

0.838±0.003 0.821±0.002**

0.980±0.003 0.971±0.002*

Regular walking Yes

No

3728 5170

46.00±0.79 46.41±0.74

0.858± 0.002 0.851± 0.001**

0.715±0.002 0.710±0.001*

0.919±0.002 0.919±0.002

3076 3564

121.7±2.32 121.1±1.88

0.982±0.002 0.974±0.002*

0.829±0.002 0.823±0.002

0.974±0.002 0.973±0.002

#

Covariates: age, residence area, smoking status, drinking status, educational level, obesity, regular exercise and walking

: Reference *: P<0.05, **: P<0.01

The means of serum ferritin in the old age group (>

50 years) were significantly higher, as compared to the young age group in women, but the differences were not apparent in men. On the other hand, the BMDs of three areas decreased according to age, and were more significant in those of the total femur and femur neck, as compared to the lumbar spine.

While the BMDs of total femur and femur neck of women and men who were rural residents were significantly higher than those for urban residents, there were no differences in serum ferritin and BMD of lumbar spine between residents of both areas, for both genders.

The means of non-smokers were significantly lower

(5)

Table 2. Differences (95% CI) in bone mineral densities of total femur, femur neck, and lumbar spine by serum ferritin level after covariate adjustmentª

Women Men

Model 1: Total femur bone mineral density

Per doubling of serum ferritin level (mg/L)

–0.0022 (–0.0043~–0.0001) –0.001 (–0.0044~0.0024)

Serum ferritin quartiles (mg/L)

≤18.09

>18.09~31.97

>31.97~60.93

>60.93

0 (Reference) –0.0019 (–0.0094~0.0055) –0.0048 (–0.012~0.0023) –0.0071 (–0.015~0.0008)

≤64.31

>64.31~98.06

>98.06~149.21

>149.21

0 (Reference) 0.0108 (0.0018~0.0198) 0.0007 (–0.0091~0.0104) –0.0048 (–0.0145~0.0049) Model 2: Femur neck bone mineral density

Per doubling of serum ferritin level (mg/L)

–0.003 (–0.0051~–0.0009) –0.0014 (–0.005~0.0023)

Serum ferritin quartiles (mg/L)

≤18.09

>18.09~31.97

>31.97~60.93

>60.93

0 (Reference) –0.0051 (–0.0124~0.0023) –0.0062 (–0.0136~0.0011) –0.0086 (–0.0163~–0.0009)

≤64.31

>64.31~98.06

>98.06~149.21

>149.21

0 (Reference) 0.0079 (–0.0015~0.0172) –0.0016 (–0.012~0.0088) –0.0071 (–0.0174~0.0032) Model 3: Lumbar spine bone mineral density

Per doubling of serum ferritin level (mg/L)

–0.0057 (–0.0082~–0.0033) 0.0034 (–0.0001~0.0068)

Serum ferritin quartiles (mg/L)

≤18.09

>18.09~31.97

>31.97~60.93

>60.93

0 (Reference) –0.0078 (–0.0167~0.001) –0.0166 (–0.0251~–0.008) 0.0189 (–0.0282~–0.0096)

≤64.31

>64.31~98.06

>98.06~149.21

>149.21

0 (Reference) 0.0137 (0.0036~0.0238) 0.0079 (–0.0023~0.018) 0.0056 (–0.0043~0.0156) ª: Adjusted for age, residence area, body mass index, smoking & drinking status, education level, regular exercise & walking for men with the addition of menopausal status, hormone treatment, and use of oral contraceptives for women.

: Mean differences in bone mineral densities of total femur, femur neck, and lumbar spine with doubling of the blood ferritin level.

than current smokers in women and past & current smokers in men, whereas only the BMDs of total femur and femur neck of female past smokers were significantly lower than those of female non-smokers, and there were no differences in BMD of the three regions among male smoking status groups.

While the mean BMDs of non-drinkers were signifi- cantly lower than for heavy drinkers in women and mild, moderate, & heavy drinkers in men, the BMDs of the three regions in non-drinkers were significantly lower than those of drinkers in women, but not in men.

Education level was a significant predictor for BMDs of the three regions, but not for serum ferritin in women and men. On the other hand, obesity was a significant predictor for BMDs of three regions in both genders, but was a significant predictor for serum ferritin only in men.

Regular exercise was a more significant predictor for BMDs of the three regions in both genders, as compared to regular walking, but regular exercise and

walking were not significant predictors for serum ferritin.

Multivariate linear regression analyses were then performed to calculate the mean differences in BMDs of total femur, femur neck, and lumbar spine by serum ferritin and to determine the significance of serum ferritin as a predictor of BMD after adjusting for age, BMI, residence area, education level, smoking &

drinking status, and regular exercise and walking for men, with addition of menopausal status, hormone treatment, and use of oral contraceptives for women (Table 2).

Log

2

-transformed serum ferritin as a continuous inde- pendent variable was a significant predictor for BMDs of the three regions (model 1-3) in women but not in men, whereas serum ferritin Q as a categorical independent variable was only a significant predictor for BMDs of femur neck and lumbar spine in women.

Using logistic regression analysis, ORs and 95% CI

values for low bone mass for chronological age were

(6)

Table 3. Odd ratios (95% CI) for low bone mass for chronological age by serum ferritin level in adult population after covariate adjustmentª

Women Men

Per doubling of serum ferritin level (mg/L)

1.082 (1.017~1.1504) 1.010 (0.933~1.0942)

Serum ferritin quartiles (mg/L)

≤18.09

>18.09~31.97

>31.97~60.93

> 60.93

1 (Reference) 1.002 (0.815~1.231) 1.203 (0.984~1.471) 1.267 (1.006~1.596)

≤64.31

>64.31~98.06

>98.06~149.21

>149.21

1 (Reference) 0.858 (0.698~1.054) 0.991 (0.793~1.237) 1.170 (0.952~1.439) ª: Adjusted for age, residence area, body mass index, smoking & drinking status, education level, regular exercise & walking for men with the addition of menopausal status, hormone treatment, and use of oral contraceptives for women.

: Odd ratios (95% CI) for low bone mass for chronological age with doubling of the blood ferritin level.

calculated for log

2

-transformed ferritin and for Qs of serum ferritin after covariate adjustment in women and men (Table 3). The covariates used in the logistic regression analysis were the same as those in regression analysis. While the OR (95% CI) for low bone mass in doubling of serum ferritin was 1.082 (1.017~1.150) in women, those of the 3rd and 4th Q of serum ferritin were 1.203 (0.984~1.471) and 1.267 (1.006~1.596) in women, respectively. There were no significant associa- tions of ferritin level and low bone mass in men.

DISCUSSION

Previous studies have indicated the adverse effects of iron on bone. In subjects with genetic hemochro- matosis, the development of osteoporosis was strongly influenced by the degree of iron overload, and BMD in the femur neck appeared to decrease with increasing hepatic iron concentration.

11,18

Increased bone iron accumulation has also been postulated to contribute to osteoporosis in patients with chronic liver disease.

18

However, there have been few epidemiological studies relating iron stores to bone loss in a general popu- lation.

16

Recently, Kim et al.

16

reported an association between high ferritin level and accelerated bone loss in a retrospective study in healthy Korean subjects. However, this study population was comprised of subjects who visited a health promotion center, and was not repre- sentative of the general population, possibly resulting in selection bias. In a representative Korean general

population, we showed that body iron stores, reflected by higher ferritin concentrations, were significantly associated with bone loss after adjustment for potential confounders in women. In this large, representative sample of South Korean women, elevated ferritin levels were associated with lower BMD levels after adjusting for various covariates, including menopausal status. In multiple linear regression analysis of log

2

-transformed serum ferritin as a continuous variable on BMD, after adjusting for various covariates, the differences in BMD levels associated with doubling of serum ferritin were -0.0022~-0.0057. The differences in BMD levels comparing participants in the highest versus the lowest Qs of serum ferritin were also -0.0086~-0.0189. In addition, serum ferritin was a risk factor for the prevalence of low bone mass for chronological age after adjusting for various covariates, including meno- pausal status. Based on ORs, doubling of serum ferritin resulted in a 8.2% increase in the risk of low bone mass. Participants in the highest Q of serum ferritin were 26.7% more likely to have low bone mass than those in the lowest serum ferritin Q. In the present study, the association between serum ferritin and low bone mass was significant regardless of the type of variable (continuous or categorical).

The mechanisms underlying the potential association

between body iron stores and low bone mass are

unclear. Both osteoblasts and osteoclasts express the

iron uptake protein transferrin receptor (TrfR), suggesting

that these cells have the ability to accumulate iron.

9,19

(7)

Yamasaki and Hagiwara

7

studied the effects of ferric ions on the proliferation, differentiation, and minerali- zation of two types of cultured osteoblasts, i.e., the MC3T3-E1 cell line and rat calvarial osteoblast-like cells. They found that iron inhibited MC3T3-E1 cell viability in a dose-dependent manner. In addition, Ishii et al.

9

reported that the mitochondrial activation pathway through iron uptake promoted osteoclast differentiation and bone-resorbing activity, and iron chelation could inhibit osteoclastic bone resorption and protected against bone loss following estrogen defi- ciency resulting from ovariectomy. Consequently, they suggested that iron overload may underlie the patho- genesis of osteoporosis characterized by excessive bone resorption. Iron also inhibits anterior pituitary synthesis of gonadotrophs. It has been suggested that brain iron results in decreased formation of gonadal hormones.

20

The tendency of iron-loaded subjects to become osteo- porotic may be enhanced by gonadal hormone defi- ciency.

21,22

Consistent with these observations, hormone replacement therapy shows promise for prevention of osteoporosis.

23

Taken together, these data suggest that increased total body iron stores could be an independent risk factor for loss of bone mass.

Very recently, Kim et al. showed that the association between higher serum ferritin level and osteoporosis is prominent in women ≥45 years of age with the same study group.

24

However, they did not adjust female related variables (menopausal status including surgical menopause, past or current hormone use, and past use of oral pill) which is very important for women health.

Menopausal status causes high ferritin levels due to cease of menstruation as well as BMD reduction. Thus menopause may be the common link that resulted in the association between higher serum ferritin level and lower bone mineral density in women ≥45 years of age. Contrary to their study, the present study showed the subclinical association between low bone mass for chronological age and serum ferritin level over all

female ages, but not limited to ≥45 years of age.

Our results indicated that the association of serum ferritin with bone mass may differ with gender.

However, the cause for this gender difference is not clear. The differences in the patterns of bone loss between women and men have been clearly demon- strated in many epidemiological studies. In women, the rate of bone loss is markedly accelerated in the early postmenopausal period and then stabilizes with aging.

25,26

In contrast, the rate of decline in bone density among men is relatively constant after attain- ment of peak bone mass or may increase with aging, partially explained by the diminishing levels of sex hormones, including testosterone and/or estradiol.

27,28

Studies focusing on how male and female hormones interact with iron in relation to bone metabolism may help to explain the gender difference in the association between iron stores and low bone mass.

The results of the present study have substantial public health implications. First, association of elevated ferritin levels with lower BMD levels was observed in a general population, and was not confined to specific clinical conditions associated with iron overload, including hemochromatosis, thalassemia, or sickle cell disease. Second, the present results indicate the impor- tance of assessing iron status when addressing BMD.

Third, it may be possible to prevent osteoporosis by identifying the population at high risk for future bone loss. In addition, serum iron level regulation may have clinical potential in osteoporosis management.

The present study had several important strengths.

First, we considered and adjusted for most potential

confounders/effect modifiers, including age, residence

area, body mass index, smoking & drinking status,

education level, regular exercise &walking for men,

with addition of menopausal status, hormone treatment,

and use of oral contraceptives for women. Second, this

study was performed in a representative sample of the

general Korean adult population. Finally, rigorous

quality control of study procedures was ensured in the

(8)

KNHANES.

The limitations of our study should also be consi- dered. First, serum ferritin is an acute-phase reactant and may be artificially elevated in the presence of acute and chronic inflammatory disorders or malig- nancies as well as in liver or kidney disease.

29,30

We did not exclude this potential confounding factor by adjusting for C-reactive protein, which was not included in the KNHANES. Second, a causal relation- ship between iron storage and low bone mass cannot be inferred because of the cross-sectional study design. An unknown third factor may be the common link that produces the association between iron storage and bone loss.

In conclusion, body iron stores, reflected by higher ferritin concentrations, were significantly associated with low bone mass after adjustment for potential confounders in the general female population.

Conflicts of interest:

All authors state that they have no conflicts of interest.

REFERENCES

1. WHO. Prevention and management of osteoporosis.

Report of a WHO Scientific Group. Geneva, World Health Organization (WHO Technical Report Series, No. 921) 2003.

2. Li GF, Pan YZ, Sirois P, Li K, Xu YJ. Iron homeostasis in osteoporosis and its clinical impli- cations. OsteoporosInt 2012;23:2403-8.

3. Crichton RR, Wilmet S, Legssyer R, Ward RJ.

Molecular and cellular mechanisms of iron homeo- stasis and toxicity in mammalian cells. J Inorg Biochem 2002;91:9-18.

4. McCord JM. Effects of positive iron status at a cellular level. Nutr Rev 1996;54:85-8.

5. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, et al. Insulin resistance

and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988;318:809-14.

6. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 2004;350:

2383-97.

7. Yamasaki K, Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicol Lett 2009;191:211- 5.

8. Yang Q, Jian J, Abramson SB, Huang X. Inhi- bitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J Bone Miner Res 2011;26:1188-96.

9. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, et al. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteo- clast activation. Nat Med 2009;15:259-66.

10. Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, et al. Bone loss caused by iron overload in a murine model: importance of oxida- tive stress. Blood 2010;116:2582-9.

11. Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 2005;16:1809- 14.

12. Lorincz G, Traub NE, Chuke PO, Hussain SF.

African haemosiderosis associated with osteoporosis and vertebral collapse. East Afr Med J 1974;51:

488-95.

13. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, et al. Bone disease in thalassemia: a frequent and still unresolved problem.

J Bone Miner Res 2009;24:543-57.

14. Sarrai M, Duroseau H, D’Augustine J, Moktan S, Bellevue R. Bone mass density in adults with sickle cell disease. Br J Haematol 2007;136:666-72.

15. Wibaux C, Legroux-Gerot I, Dharancy S, Boleslawski

E, Declerck N, Canva V, et al. Assessing bone

status in patients awaiting liver transplantation.

(9)

Joint Bone Spine 2011;78:387-91.

16. Kim BJ, Ahn SH, Bae SJ, Kim EH, Lee SH, Kim HK, et al. Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study. J Bone Miner Res 2012;27:2279-90.

17. Kim Y, Lee BK. Associations of blood lead, cadmium, and mercury with estimated glomerular filtration rate in the Korean general population:

analysis of 2008-2010 Korean National Health and Nutrition Examination Survey data. Environ Res 2012;118:124-9.

18. Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, et al. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 1997;24:

1809-13.

19. Kasai K, Hori MT, Goodman WG. Characterization of the transferrin receptor in UMR-106-01 osteo- blast-like cells. Endocrinology 1990;126:1742-9.

20. Akhlaghpoor S, Ghahari A, Morteza A, Khalilzadeh O, Shakourirad A, Alinaghizadeh MR. Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients. Clin Neuroradiol 2012;22:211-7.

21. Pietrapertosa AC, Minenna G, Colella SM, Santeramo TM, Renni R, D'Amore M. Osteopro- tegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.

Panminerva Med 2009;51:17-23.

22. Weinberg ED. Role of iron in osteoporosis. Pediatr Endocrinol Rev 2008;6 Suppl 1:81-5.

23. Chatterjee R, Katz M, Bajoria R. Use of hormone replacement therapy for correction of high turnover bone disease in hypogonadal β-Thalassemia major patients presenting with osteoporosis: comparison with idiopathic premature ovarian failure. Hemo- globin 2011;35:653-8.

24. Kim BJ, Lee SH, Koh JM, Kim GS. The associ- ation between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age (KNHANES 2008-2010). Osteoporos Int 2013;24:2627-37.

25. Pouilles JM, Tremollieres F, Ribot C. The effects of menopause on longitudinal bone loss from the spine. Calcif Tissue Int 1993;52:340-3.

26. Pouilles JM, Tremollieres F, Ribot C. Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res 1995;10:1531-6.

27. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 2008;178:1660-8.

28. Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309:691-5.

29. Brugnara C. Iron deficiency and erythropoiesis: New diagnostic approaches. Clin Chem 2003;49:1573-8.

30. Gabay C, Kushner I. Acute-phase proteins and

other systemic responses to inflammation. N Engl J

Med 1999;340:448-54.

수치

Table  1.  Means  and  standard  error  of  serum  ferritin  and  bone  mineral  densities  of  adult  population  by  gender  and  classification  variables  after  covariate  adjustment
Table  2.  Differences  (95%  CI)  in  bone  mineral  densities  of  total  femur,  femur  neck,  and  lumbar  spine  by  serum  ferritin  level  after  covariate  adjustmentª
Table  3.  Odd  ratios  (95%  CI)  for  low  bone  mass  for  chronological  age  by  serum  ferritin  level  in  adult  population  after  covariate  adjustmentª

참조

관련 문서

Comparison of the prevalence of Malnutrition and Overweight, Obesity between South Korean families and North Korean refugees families 15 Table 5.. Comparison of the

Impact of age at first childbirth on glucose tolerance status in postmenopausal women: the 2008-2011 Korean National Health and Nutrition Examination

Age-related changes in the prevalence of osteoporosis according to gender and skeletal site: The Korea National Health and Nutrition Examination Survey 2008-2010..

Objective: The purpose of this study is to investigate the relationship between depression and evening meals for adult women by using the National Health and Nutrition Survey

socioeconomic status and thyroid cancer prevalence; Based on the korean National Health and Nutrition Examination Survey2010-2011. Jung YI, Kim

Prevalence of Undiagnosed Diabetes and Related Factors in Korean Postmenopausal Women:.. The 2011-2012 Korean National Health and

Objective: The purpose of this study is to use it as a basis for the health care guidelines for the muscle mass and cardiovascular disease of Korean population by

The ratio of clinical nurses with good health (the group with a high health status score in the survey) and clinical nurses with poor health (the group with a low health status